Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Interim phase II results for Mesoblast's mesenchymal precursor cells for intervertebral disc repair

April 23, 2013

TiGenix reports phase IIa study results for Cx-611

April 22, 2013

Cipla launches biosimilar of etanercept in India

April 22, 2013

Pluristem Therapeutics expands PLX pipeline in orthopedics and sports medicine

April 19, 2013

Galapagos expands phase IIb trial of GLPG-0634 in rheumatoid arthritis

April 18, 2013

Sarepta reports results from extension study of eteplirsen in Duchenne muscular dystrophy

April 10, 2013

Proximagen prepares new SSAO inhibitors

April 9, 2013

AstraZeneca reports topline results from phase III fostamatinib study

April 9, 2013

Novel SSAO inhibitors prepared at Proximagen

April 3, 2013

Pharmacodynamics of new rituximab biosimilar evaluated

April 2, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...